PE
TOI icon

Point72 Europe’s The Oncology Institute TOI Stock Holding History

Point72 Europe’s Portfolio TOI Stock Details TOI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$12.5K Buy
+3,572
New +$12.2K ﹤0.01% 515

Other funds holding TOI

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Point72 Europe's TOI Position: Q3 2025 in Review

Point72 Europe opened a new position in The Oncology Institute (TOI) in Q3 2025: 3,572 shares worth $12.5K. The stake represents ﹤0.01% of the portfolio and ranks #515 among its holdings.

108 funds tracked by Wall St. Rank hold TOI as of Q3 2025.

  • Point72 Europe held 3,572 shares of The Oncology Institute worth $12.5K as of Q3 2025.
  • The Oncology Institute was a new Point72 Europe position in Q3 2025.
  • The Oncology Institute made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #515 holding.
  • 108 funds tracked by Wall St. Rank held The Oncology Institute as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.